Cargando…
Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton’s Jelly–Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy
We investigated whether thrombin preconditioning of human Wharton’s jelly–derived mesenchymal stem cells (MSCs) improves paracrine potency and thus the therapeutic efficacy of naïve MSCs against severe hypoxic ischemic encephalopathy (HIE). Thrombin preconditioning significantly enhances the neuropr...
Autores principales: | Kim, Young Eun, Sung, Se In, Chang, Yun Sil, Ahn, So Yoon, Sung, Dong Kyung, Park, Won Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566845/ https://www.ncbi.nlm.nih.gov/pubmed/31137455 http://dx.doi.org/10.3390/ijms20102477 |
Ejemplares similares
-
Preclinical assessment of thrombin‐preconditioned human Wharton’s jelly‐derived mesenchymal stem cells for neonatal hypoxic‐ischaemic brain injury
por: Noh, Jung‐Ho, et al.
Publicado: (2021) -
Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy
por: Ahn, So Yoon, et al.
Publicado: (2018) -
Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy
por: Park, Won Soon, et al.
Publicado: (2015) -
Thrombin Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage Induced Neonatal Rats
por: Jung, So Yeon, et al.
Publicado: (2022) -
Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study
por: Kabataş, Serdar, et al.
Publicado: (2018)